VGLL3 and systemic lupus erythematosus: VGLL3 is overexpressed in cancer cells, such as those from breast tumors and osteosarcomas [22], and is involved in autoimmune diseases, including lupus, scleroderma, and Sjögren’s syndrome [28,29].